| Literature DB >> 16002208 |
Henrik Gréen1, Per Rosenberg, Peter Söderkvist, György Horvath, Curt Peterson.
Abstract
Mutations in the beta-tubulin gene have been proposed as a resistance mechanism to paclitaxel. We therefore investigated the presence of mutations in the beta-tubulin M40 gene in 40 ovarian tumours (16 paraffin-embedded and 24 freshly frozen) selected for good or poor response to chemotherapy with paclitaxel or non-tubulin-affecting regimens. The presence of mutations was investigated using single strand conformation analysis followed by sequencing of the products with altered mobility. No sequence variants in the exons of the beta-tubulin M40 gene were detected. Non-reproducible shifts were identified, in eight out of 16 paraffin embedded samples. This may explain some of the previously published discrepancies. In conclusion, sequence variants in the beta-tubulin M40 gene are rare and are unlikely to be a clinically relevant explanation of resistance to paclitaxel.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16002208 DOI: 10.1016/j.canlet.2005.05.025
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679